Shanghai Junshi Ownership

688180 Stock   29.97  0.13  0.43%   
Shanghai Junshi Bios shows a total of 765.58 Million outstanding shares. Shanghai Junshi Bios maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Shanghai Junshi in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Shanghai Junshi, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of December 18, 2024, Dividends Paid is expected to decline to about 14.3 M. As of December 18, 2024, Common Stock Shares Outstanding is expected to decline to about 951.7 M. The current year's Net Loss is expected to grow to about (2.1 B).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shanghai Junshi Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Shanghai Stock Ownership Analysis

About 30.0% of the company shares are owned by insiders or employees . The book value of Shanghai Junshi was presently reported as 28.15. The company recorded a loss per share of 1.97. Shanghai Junshi Bios had not issued any dividends in recent years. For more info on Shanghai Junshi Biosciences please contact Cong Li at 86 21 6105 8800 or go to https://www.junshipharma.com.

Shanghai Junshi Outstanding Bonds

Shanghai Junshi issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Shanghai Junshi Bios uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Shanghai bonds can be classified according to their maturity, which is the date when Shanghai Junshi Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Junshi financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Junshi security.